Related Experiment Videos
Sustained antidepressant effect of PEA replacement
1Rush University and the Center for Creative Development, Chicago, Illinois, USA.
The Journal of Neuropsychiatry and Clinical Neurosciences
|January 1, 1996
Summary
Phenylethylamine (PEA) shows sustained antidepressant effects in most patients, offering relief for depression, even in those unresponsive to standard treatments. This neuroamine improves mood rapidly without causing tolerance.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Phenylethylamine (PEA) is an endogenous neuroamine with stimulant properties.
- A PEA deficit is hypothesized to contribute to certain forms of depression.
- PEA has demonstrated antidepressant effects in 60% of patients.
Observation:
- Fourteen patients with major depressive episodes were treated with PEA (10-60 mg/day) and selegiline (10 mg/day).
- Patients were re-evaluated after 20-50 weeks of continuous treatment.
- The study observed the long-term efficacy and side effects of PEA treatment.
Findings:
- Antidepressant response was maintained in 12 out of 14 patients.
- Effective PEA dosage remained consistent over the treatment period.
- No significant side effects were reported during the study.
- PEA provided sustained depression relief, including in patients resistant to other treatments.
- PEA demonstrated rapid mood improvement comparable to amphetamine without inducing tolerance.
Implications:
- PEA may be a viable long-term treatment for major depressive episodes.
- PEA offers a potential therapeutic option for treatment-resistant depression.
- Further research into PEA's neurobiological mechanisms in depression is warranted.